Author(s): Huang DP, Ye XH, Jin C, Huang DP, Ye XH, Jin C
Abstract Share this page
Abstract Breast cancer in men is a rare cancer manifestation. In this article we report a case of male breast cancer with liver metastases, which showed a good response to a combined treatment of bevacizumb and paclitaxel, suggesting a useful option for the first-line treatment of patients with recurrent HER2-negative male breast cancer. And further assessment in a randomized clinical trial is needed.
This article was published in Int J Clin Exp Med
and referenced in Journal of Surgery